India to United States: Cabozantinib Export Trade Route

The India to United States Cabozantinib corridor is one of India's established pharmaceutical export routes, with 29 shipments documented worth a combined $10.1K USD. The route is dominated by KOIT BIOPHARMA PRIVATE LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's cabozantinib manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $347 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with cabozantinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 31.5%, placing it at rank #15 among India's top cabozantinib export destinations globally.

On the import side, key buyers of Indian cabozantinib in United States include NA, COMERCIALIZADORA MEDENOR SA DE CV, ANGEL RENTERIA.. and 10 others. NA is the single largest importer with 2 shipments valued at $2.1K USD.

India's cabozantinib exports to United States are driven primarily by a handful of large-scale manufacturers. KOIT BIOPHARMA PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — KOIT BIOPHARMA PRIVATE LIMITED, ATLAS ENTERPRISES, VINAYAK ASSOCIATES — together account for 87% of total trade value on this route. The average shipment value of $347 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cazanat 40mg tab / cabozantinib and cazanat 60mg tab cabozantinib, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 2 shipments worth $2.1K USD — representing 21% of all cabozantinib imports from India on this route. A total of 13 buyers are active on this corridor.